Blood filtering approach for preeclampsia moves forward
NCT ID NCT03188900
First seen Mar 28, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study collected blood samples from 236 pregnant women with and without preeclampsia. The goal was to test a new treatment that filters out a harmful protein called sFlt-1 from the blood. The research aims to help develop a therapy that could restore normal blood vessel function in preeclampsia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Cochin
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.